Vanguard Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.7M | Buy |
|
|||||
|
2025
Q1 | $89.9M | Sell |
|
|||||
|
2024
Q4 | $117M | Sell |
|
|||||
|
2024
Q3 | $96.6M | Buy |
|
|||||
|
2024
Q2 | $54.4M | Buy |
|
|||||
|
2024
Q1 | $48.3M | Buy |
|
|||||
|
2023
Q4 | $49.6M | Buy |
|
|||||
|
2023
Q3 | $41.7M | Buy |
|
|||||
|
2023
Q2 | $64.6M | Buy |
|
|||||
|
2023
Q1 | $89.6M | Buy |
|
|||||
|
2022
Q4 | $73.9M | Buy |
|
|||||
|
2022
Q3 | $83.3M | Buy |
|
|||||
|
2022
Q2 | $80.7M | Sell |
|
|||||
|
2022
Q1 | $99.2M | Sell |
|
|||||
|
2021
Q4 | $120M | Buy |
|
|||||
|
2021
Q3 | $93.7M | Buy |
|
|||||
|
2021
Q2 | $55.9M | Sell |
|
|||||
|
2021
Q1 | $99.9M | Buy |
|
|||||
|
2020
Q4 | $92.8M | Buy |
|
|||||
|
2020
Q3 | $59.5M | Buy |
|
|||||
|
2020
Q2 | $60.6M | Buy |
|
|||||
|
2020
Q1 | $37.6M | Buy |
|
|||||
|
2019
Q4 | $35.8M | Buy |
|
|||||
|
2019
Q3 | $27.4M | Buy |
|
|||||
|
2019
Q2 | $44M | Buy |
|
|||||
|
2019
Q1 | $47.9M | Buy |
|
|||||
|
2018
Q4 | $45.9M | Buy |
|
|||||
|
2018
Q3 | $55.4M | Buy |
|
|||||
|
2018
Q2 | $51.9M | Buy |
|
|||||
|
2018
Q1 | $39.5M | Buy |
|
|||||
|
2017
Q4 | $35.9M | Buy |
|
|||||
|
2017
Q3 | $42M | Buy |
|
|||||
|
2017
Q2 | $31.7M | Buy |
|
|||||
|
2017
Q1 | $27.9M | Buy |
|
|||||
|
2016
Q4 | $26.6M | Buy |
|
|||||
|
2016
Q3 | $29.8M | Buy |
|
|||||
|
2016
Q2 | $22.4M | Buy |
|
|||||
|
2016
Q1 | $16.2M | Buy |
|
|||||
|
2015
Q4 | $22.6M | Buy |
|
|||||
|
2015
Q3 | $23.3M | Buy |
|
|||||
|
2015
Q2 | $34.4M | Buy |
|
|||||
|
2015
Q1 | $17.3M | Buy |
|
|||||
|
2014
Q4 | $7.83M | Buy |
|
|||||
|
2014
Q3 | $3.67M | Buy |
|
|||||
|
2014
Q2 | $3.82M | Buy |
|
|||||
|
2014
Q1 | $5.85M | Buy |
|